Daiichi Sankyo’s Bid For Ranbaxy To Be Complete Soon
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo President Takashi Shoda announced Oct. 8 that the company's take over bid for Ranbaxy will be completed soon. According to the offer, the company plans to acquire 50.1 percent of Ranbaxy shares. Shoda stated that the company will be able to obtain the target shares through allocation of new shares to a third party and share purchase from the founding family. Ranbaxy could become a Daiichi Sankyo subsidiary as early as the end of the year. The offer received a green light Oct.3 from the Indian government and an approval from India's central bank is expected soon. (Click here for more - Japanese language